Shumway Capital
Shumway Capital is a growth focused investment firm that partners with management teams to help accelerate their companies’ growth.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Shumway Capital Information
Geographic Data
Address: 28 Havemeyer Place
City: Greenwich
State: CT
Zip: 06830
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
2,294,713Website Global Rank
8,237Website Monthly Traffic
Twitter Followers
Description
Shumway Capital is an investment firm that uses a unique growth-focused investment model. As entrepreneurs themselves, the investment team has first-hand knowledge of how to help other companies accelerate their growth and realize their specific visions. The firm’s partners invest their own capital and provide a permanent capital base for their investments. They focus on high-growth businesses across a wealth of industries and have a collaborative approach that enables the management team and the company to continue operating their business effectively without any disruption.
Contact Phone:
+12034858550
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2018 | Finch Therapeutics | Series B | 0 |
| 9/2021 | Elligo Health Research | Series E | 0 |
| 5/2019 | Elligo Health Research | Series C | 0 |
| 7/2017 | Artsy | Series D | 0 |
| 9/2020 | Finch Therapeutics | Series D | 0 |
| 3/2018 | Elligo Health Research | Series B | 0 |
| 3/2015 | Trumid | Series A | 8.3M |
| 7/2021 | Vedanta Biosciences | Series D | 0 |
| 3/2016 | Elligo Health Research | Series A | - |
| 8/2019 | Finch Therapeutics | Series C | 0 |
| 5/2019 | Vedanta Biosciences | Series C | 18.5M |
| 9/2021 | Elligo Health Research | Series E | 0 |
| 7/2021 | Vedanta Biosciences | Series D | 0 |
| 9/2020 | Finch Therapeutics | Series D | 0 |
| 8/2019 | Finch Therapeutics | Series C | 0 |
| 5/2019 | Vedanta Biosciences | Series C | 0 |
| 5/2019 | Elligo Health Research | Series C | 0 |
| 3/2018 | Elligo Health Research | Series B | 0 |
| 3/2018 | Finch Therapeutics | Series B | 0 |
| 7/2017 | Artsy | Series D | 0 |
| 3/2016 | Elligo Health Research | Series A | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
